Journal article

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Benoit Funalot, Pierre-Marie Gonnaud, Arnaud Lacour, Yann Pereon, Odile Dubourg, Jean Pouget, Joelle Micallef, Jerome Franques, Marie-Noelle Lefebvre, Karima Ghorab, Mahmoud Al-Moussawi, Vincent Tiffreau, Marguerite Preudhomme, Armelle Magot, Laurene Leclair-Visonneau, Tanya Stojkovic, Laura Bossi Show all

Orphanet Journal of Rare Diseases | BMC | Published : 2014